Higher CAD-Measured Values, Poorer Outcomes in Some Breast Cancers

Article

CAD-measured peak enhancement at preoperative MRI of women with primary operable breast cancer and outcomes.

Women with primary operable breast cancer who have higher values of computer-aided diagnosis (CAD) peak enhancement and washout component at preoperative MR imaging have a poor disease-free survival rate, according to a study published in Radiology.

Researchers from South Korea performed a retrospective study to investigate the relationship between the kinetic features of breast cancer assessed with CAD at preoperative MR imaging and disease-free survival in patients with primary operable invasive breast cancer.

A total of 329 women with a mean age of 52.9 were included in the study. Median follow-up was 50 months. All women had newly diagnosed invasive breast cancer and had undergone preoperative MR imaging and surgery between January 2012 and February 2013. All MR images were retrospectively reviewed by using a commercially available CAD system. The kinetic parameters use for each lesion included:

Peak enhancement, which is the highest pixel signal intensity in the first series obtained after administration of contrast material

Angio-volume, the total volume of the enhancing lesion

Delayed enhancement profiles, the proportions of washout, plateau, and persistently enhancing component within a tumor

The results showed that there were 36 recurrences at 50 months. The CAD-measured peak enhancement at preoperative MR imaging enabled differentiation between patients with and patients without recurrence (area under the receiver operating characteristic curve = 0.728). The Multivariate Cox analysis showed that a higher peak enhancement, a higher washout component, and lymphovascular invasion at histopathologic examination were associated with poorer disease-free survival.

The researchers concluded that higher values of CAD-measured peak enhancement and washout component at preoperative MR imaging were significantly associated with poorer disease-free survival of patients with primary operable breast cancer.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Related Content
© 2025 MJH Life Sciences

All rights reserved.